Lee's Pharmaceutical Holdings Ltd. (L1PA)

Overview

Lee's Pharmaceutical Holdings Limited is a prominent entity focused on the development, manufacturing, marketing, and sales of pharmaceutical products, with its principal operations centered in the People's Republic of China. Founded in 1994 and stationed in Sha Tin, Hong Kong, the company secures a diversified interest across various diseases domains such as cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. Its business model is divided into two main segments: Proprietary and Generic Products; and Licensed-In Products, facilitating a dynamic approach towards offering both self-developed, generic, and licensed-in pharmaceutical solutions.

Products and Services

• Nadroparin Calcium injection and Livaracine - These are utilized in the treatment of blood clots and deep vein thrombosis, showcasing the company's focus on cardiovascular health.
• Yallaferon - An antiviral medication designed to address viral infections, underscoring Lee's commitment to infectious diseases.
• Slounase - A hemostatic agent, indicating the company’s endeavors in surgery and wound care.
• Eyprotor - Used for treating corneal ulcers, this product highlights the company's focus on ocular health.
• Treprostinil injection - Administered for pulmonary arterial hypertension, reflecting Lee's Pharmaceutical’s investment in respiratory conditions.
• Fondaparinux sodium injection - Another solution for deep vein thrombosis, further emphasizing the company's commitment to cardiovascular health.
• Sodium Phenylbutyrate Granules - Aimed at treating urea cycle disorders, spotlighting the company's interest in metabolic conditions.
• Carnitene, Sancuso, Bredinin, Centraxal Plus, Episil, Ferplex, Gaslon N - These licensed-in products treat a variety of conditions ranging from carnitine deficiency, chemotherapy-induced nausea, immunosuppression in renal transplantation, acute otitis media, oral mucositis pain, iron deficiency anemia, to gastric ulcers and gastritis, illustrating the breadth of Lee’s Pharmaceutical’s portfolio.
• Intrarosa, Adasuve, Mictonorm, Natulan, Omacor, Zanidip, Rasilez, Readyfusor, Teglutik, Trittico, Unidrox, Dicoflor, VSL#3, Zingo - These licensed-in products cover treatments for vulvovaginal atrophy, agitation associated with schizophrenia or bipolar I disorder, urinary incontinence, Stage III and IV Hodgkin's disease, Omega-3-acid ethyl esters deficiencies, hypertension, post-operative pain management, amyotrophic lateral sclerosis, insomnia/depression, urinary and respiratory tract infections, probiotics, and as topical local analgesics. This diverse range underscores Lee's Pharmaceutical's dedication to addressing a wide array of health concerns.